Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
822.00    14.00 (1.73%)
Bid:
816.00
Ask:
819.00
Spread: 3.00 (0.368%)
Market Cap: £1.14b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

11 May 2022 09:56

RNS Number : 0942L
Savills PLC
11 May 2022
 

 

11 May 2022

SAVILLS PLC

("Savills" or "the Company")

Trading update

 

Ahead of its Annual General Meeting (AGM) to be held at 12 noon today at Savills, 33 Margaret Street, London W1G 0JD, Savills plc, the international real estate advisor issues the following trading update:

 

· Both our Transactional and Less Transactional businesses are performing in line with our expectations for the period to date

· The war in Ukraine, inflation and the rising interest rate cycle have somewhat tempered transactional activity, particularly in the smaller lot sizes both in terms of capital transactions and leasing take-up with activity skewed towards larger transactions

· Residential markets in the UK have performed well albeit stock availability continues to be significantly reduced compared with the equivalent prior year period

· Continued COVID and travel restrictions, particularly in Hong Kong and Mainland China have reduced activity in both the leasing and capital transaction markets

· Subject to exacerbation of current geopolitical risks and any potential further waves of COVID-related restrictions, the Board remains confident in its expectations for the full year

 

 

Mark Ridley, Chief Executive, commented:

 

"2022 has presented a number of heightened macro-economic, geopolitical, supply chain and, in some locations, continued COVID-related risks both to investors and corporates and to people's personal lives. I am delighted with the responses of our people and our clients specifically in respect of support for Ukraine, but also for their resilient approach to doing business in challenging circumstances. We have performed well so far this year and, with our strong balance sheet, we are continuing to undertake a variety of business development activities across the Group to further enhance our service to clients worldwide."

 

 

Trading Update

 

In the Asia Pacific region, the recovery has been most evident throughout the period in Singapore, Australia, Japan and Vietnam. Greater China, although below our original expectations for 2022, has performed resiliently in the face of continued significant COVID-related restrictions. Throughout the period, our substantial Property and Facilities Management business in the region has performed well.

 

In the UK, our performance has continued strongly, driven primarily by the continued high levels of activity in the transactional markets, albeit residential activity has, as anticipated, been somewhat lower than the unusually strong 2021 comparative period. Our less transactional service lines have performed in line with our expectations to date. Overall, the UK has traded slightly better than anticipated.

 

In Continental Europe and the Middle East, where Savills is more dependent upon transactional activity, performance has improved compared with both the prior period and our original expectations for the year to date, although we remain conscious that supply chain issues (particularly energy), inflation and the rising interest rate environment pose a challenge to a number of European economies.

 

In North America, where the Group is substantially dependent upon leasing activity by corporate occupiers, our business performance has been in line with our expectations and has improved significantly over the prior comparative period.

 

Savills Investment Management has traded in line with our expectations, albeit in an environment where a number of markets and sectors remain challenging for the deployment of equity capital. Debt markets have remained highly attractive for investors and DRC Savills has performed well to date.

 

 

Outlook

 

Savills has traded well so far in 2022. There remains significant investor interest in the secure income characteristics of real estate and occupiers are progressively focussing on improving the sustainability characteristics of their portfolios as well as creating environments in which staff can thrive. These positive trends stand against a backdrop of geopolitical, economic, practical (supply chain) and, in some cases, COVID-related challenges.

 

Whilst the Board is mindful of the backdrop, it remains confident in its expectations for 2022 as a whole.

 

We anticipate announcing the Group's Half Year Results for the six months to 30 June on 11th August 2022.

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Mark Burgess

Elizabeth Snow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFIFVTEDILLIF
Date   Source Headline
1st Oct 202511:00 amRNSTotal Voting Rights
29th Sep 202512:09 pmRNSDirector Declaration
25th Sep 20257:00 amRNSDirectorship Change
11th Sep 202512:38 pmRNSDirector/PDMR Shareholding
5th Sep 20252:00 pmRNSAdditional Listing
14th Aug 20257:00 amRNSHalf-year Report
12th Aug 20252:39 pmRNSDirector/PDMR Shareholding
1st Aug 20253:41 pmRNSHolding(s) in Company
21st Jul 20252:03 pmRNSBlock listing Interim Review
16th Jul 20251:44 pmRNSHolding(s) in Company
15th Jul 20254:20 pmRNSHolding(s) in Company
14th Jul 20251:14 pmRNSHolding(s) in Company
14th Jul 202510:18 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20255:20 pmRNSDirector/PDMR Shareholding
23rd Jun 20252:45 pmRNSHolding(s) in Company
20th Jun 20254:00 pmRNSAdditional Listing
12th Jun 20258:15 amRNSDirector/PDMR Shareholding
12th Jun 20258:10 amRNSDirector/PDMR Shareholding
10th Jun 20255:57 pmRNSDirector/PDMR Shareholding
4th Jun 202512:12 pmRNSHolding(s) in Company
2nd Jun 20253:05 pmRNSHolding(s) in Company
2nd Jun 20258:58 amRNSHolding(s) in Company
22nd May 20255:31 pmRNSHolding(s) in Company
15th May 20254:06 pmRNSHolding(s) in Company
14th May 20252:38 pmRNSResult of AGM
14th May 20257:00 amRNSAGM Statement
13th May 20254:01 pmRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSavills Announces Succession Plan
7th Apr 20254:18 pmRNSAnnual Report and AGM Notice
1st Apr 202511:00 amRNSTotal Voting Rights
24th Mar 20252:18 pmRNSHolding(s) in Company
21st Mar 20253:00 pmRNSAdditional Listing
20th Mar 20259:21 amRNSDirector/PDMR Shareholding
18th Mar 20252:27 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSFinal Results
12th Mar 202511:00 amRNSDirector/PDMR Shareholding
17th Feb 20254:43 pmRNSBlock listing Interim Review
12th Feb 202511:10 amRNSDirector/PDMR Shareholding
11th Feb 20252:32 pmRNSHolding(s) in Company
7th Feb 20253:51 pmRNSHolding(s) in Company
3rd Feb 202511:00 amRNSTotal Voting Rights
29th Jan 20252:28 pmRNSHolding(s) in Company
28th Jan 20253:47 pmRNSHolding(s) in Company
22nd Jan 202511:47 amRNSBlock listing Interim Review
16th Jan 20257:00 amRNSYear End Trading Update
13th Jan 20252:35 pmRNSDirector/PDMR Shareholding
2nd Jan 20253:00 pmRNSTotal Voting Rights
16th Dec 20244:03 pmRNSHolding(s) in Company
12th Dec 202411:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.